| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |